# Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes

Study · id `cardio:ct-nct06517576` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06517576](<https://clinicaltrials.gov/study/NCT06517576>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06517576

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 150 participants.

## Technical summary

Registry record NCT06517576. Randomized; no masking; primary purpose prevention. Start 2024-12-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT06517576, source copy `cardio:ctgov-nct06517576-2026-11-18`, retrieved 2026-11-18)
- Started: 2024-12-01 (actual) (ClinicalTrials.gov record NCT06517576, source copy `cardio:ctgov-nct06517576-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06517576, source copy `cardio:ctgov-nct06517576-2026-11-18`, retrieved 2026-11-18)
- Completion: 2027-01-30 (anticipated) (ClinicalTrials.gov record NCT06517576, source copy `cardio:ctgov-nct06517576-2026-11-18`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06517576, source copy `cardio:ctgov-nct06517576-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06517576-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): Blood glucose monitor with Digital Platform and Health Coaching
- Intervention (Device): Continuous glucose monitor
- Intervention (Other): Usual Care
- Lead sponsor: Lawndale Christian Health Center
- Lead sponsor class: OTHER
- Collaborator: Northwestern University
- Collaborator class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH
- Collaborator: University of Chicago
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Northwestern University (`cardio:org-northwestern-university`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)
- Registry lists this organization as a collaborator: University of Chicago (`cardio:org-university-of-chicago`)

## Provenance

Content hash: 36df2677a410f793641df0a6ab6c12bfe86bdbe5337e5808f98fc0fd690f91fd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
